Derek Archila
Stock Analyst at Wells Fargo
(4.91)
# 254
Out of 5,133 analysts
975
Total ratings
56.3%
Success rate
19.9%
Average return
Main Sectors:
Stocks Rated by Derek Archila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYTX Kyverna Therapeutics | Reiterated: Buy | $33 | $5.03 | +556.06% | 17 | Nov 13, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $326 → $330 | $267.07 | +23.56% | 46 | Nov 13, 2026 | |
| ALMS Alumis | Maintained: Buy | $25 → $18 | $6.13 | +193.64% | 13 | Nov 13, 2026 | |
| ANNX Annexon | Reiterated: Buy | $27 | $3.97 | +580.10% | 24 | Nov 10, 2026 | |
| IMVT Immunovant | Rated: Buy | $45 → $47 | $35.05 | +34.09% | 31 | Nov 10, 2026 | |
| SEPN Septerna | Reiterated: Buy | $61 | $41.86 | +45.72% | 16 | Nov 10, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $34 → $39 | $30.48 | +27.95% | 22 | Nov 9, 2026 | |
| ATYR aTyr Pharma | Rated: Hold | $40 → $4 | $6.21 | -35.59% | 14 | Nov 6, 2026 | |
| GLUE Monte Rosa Therapeutics | Rated: Buy | $29 → $25 | $9.31 | +168.53% | 18 | Nov 6, 2026 | |
| QTTB Q32 Bio | Reiterated: Buy | $59 | $8.82 | +568.93% | 12 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $220 | $156.65 | +40.44% | 9 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $6.87 | +60.12% | 27 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $155 | $109.86 | +41.09% | 62 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 | $48.70 | +43.74% | 6 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $15.60 | +28.21% | 26 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 | $78.17 | +30.48% | 8 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.17 | +247.00% | 4 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $128 → $127 | $121.70 | +4.35% | 46 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $151 | $127.17 | +18.74% | 27 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $44 | $38.13 | +15.39% | 3 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,356 → $1,336 | $981.33 | +36.14% | 82 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 → $124 | $83.23 | +48.98% | 6 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.08 | +362.96% | 3 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $415.96 | -3.84% | 1 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $8.50 | +194.12% | 14 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $1.58 | +1,102.53% | 4 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $19.32 | +55.28% | 1 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 | $28.53 | +152.37% | 25 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $10.55 | +42.18% | 1 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $750 | $951.19 | -21.15% | 1 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $2.77 | +261.01% | 14 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $35 | $69.84 | -49.89% | 26 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $81 | $47.77 | +69.56% | 27 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $56 | $61.40 | -8.79% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $58.12 | n/a | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 | $63.36 | n/a | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $21.04 | n/a | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $30 | $9.59 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $1.33 | n/a | 16 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $26.47 | n/a | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $1.68 | n/a | 17 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $63.74 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $11.29 | $0.82 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $1.32 | n/a | 11 | Jun 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $0.3259 | n/a | 34 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $6.36 | n/a | 20 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $26.39 | n/a | 27 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 → $97 | $33.93 | n/a | 15 | May 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $130 | $425.21 | n/a | 10 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $11.43 | n/a | 20 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $11.67 | n/a | 28 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $27.58 | n/a | 11 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.12 → €17.01 | €3.59 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $19 | $3.88 | n/a | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €94.62 → €96.00 | €31.04 | n/a | 2 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €11.00 | €10.84 | n/a | 7 | Sep 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $36.46 | n/a | 14 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.95 | n/a | 31 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $11.16 | n/a | 12 | Apr 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.0004 | n/a | 11 | Mar 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $16.18 | n/a | 6 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.383 | n/a | 8 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $20.67 | n/a | 1 | Oct 3, 2017 |
Kyverna Therapeutics
Nov 13, 2026
Reiterated: Buy
Price Target: $33
Current: $5.03
Upside: +556.06%
Ascendis Pharma
Nov 13, 2026
Maintained: Buy
Price Target: $326 → $330
Current: $267.07
Upside: +23.56%
Alumis
Nov 13, 2026
Maintained: Buy
Price Target: $25 → $18
Current: $6.13
Upside: +193.64%
Annexon
Nov 10, 2026
Reiterated: Buy
Price Target: $27
Current: $3.97
Upside: +580.10%
Immunovant
Nov 10, 2026
Rated: Buy
Price Target: $45 → $47
Current: $35.05
Upside: +34.09%
Septerna
Nov 10, 2026
Reiterated: Buy
Price Target: $61
Current: $41.86
Upside: +45.72%
Viridian Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $34 → $39
Current: $30.48
Upside: +27.95%
aTyr Pharma
Nov 6, 2026
Rated: Hold
Price Target: $40 → $4
Current: $6.21
Upside: -35.59%
Monte Rosa Therapeutics
Nov 6, 2026
Rated: Buy
Price Target: $29 → $25
Current: $9.31
Upside: +168.53%
Q32 Bio
Nov 5, 2026
Reiterated: Buy
Price Target: $59
Current: $8.82
Upside: +568.93%
Nov 4, 2026
Reiterated: Hold
Price Target: $220
Current: $156.65
Upside: +40.44%
Nov 4, 2026
Reiterated: Hold
Price Target: $11
Current: $6.87
Upside: +60.12%
Nov 4, 2026
Reiterated: Buy
Price Target: $155
Current: $109.86
Upside: +41.09%
Nov 4, 2026
Rated: Buy
Price Target: $70
Current: $48.70
Upside: +43.74%
Nov 3, 2026
Reiterated: Hold
Price Target: $25 → $20
Current: $15.60
Upside: +28.21%
Oct 30, 2026
Reiterated: Buy
Price Target: $102
Current: $78.17
Upside: +30.48%
Oct 30, 2026
Reiterated: Buy
Price Target: $11
Current: $3.17
Upside: +247.00%
Oct 29, 2026
Reiterated: Hold
Price Target: $128 → $127
Current: $121.70
Upside: +4.35%
Oct 29, 2026
Reiterated: Buy
Price Target: $151
Current: $127.17
Upside: +18.74%
Oct 27, 2026
Rated: Buy
Price Target: $30 → $44
Current: $38.13
Upside: +15.39%
Oct 22, 2026
Reiterated: Buy
Price Target: $1,356 → $1,336
Current: $981.33
Upside: +36.14%
Oct 20, 2026
Reiterated: Buy
Price Target: $86 → $124
Current: $83.23
Upside: +48.98%
Oct 16, 2026
Reiterated: Buy
Price Target: $5
Current: $1.08
Upside: +362.96%
Oct 16, 2026
Reiterated: Buy
Price Target: $400
Current: $415.96
Upside: -3.84%
Oct 16, 2026
Reiterated: Buy
Price Target: $25
Current: $8.50
Upside: +194.12%
Oct 16, 2026
Reiterated: Buy
Price Target: $19
Current: $1.58
Upside: +1,102.53%
Oct 16, 2026
Reiterated: Buy
Price Target: $30
Current: $19.32
Upside: +55.28%
Oct 15, 2026
Reiterated: Buy
Price Target: $72
Current: $28.53
Upside: +152.37%
Oct 15, 2026
Reiterated: Hold
Price Target: $15
Current: $10.55
Upside: +42.18%
Oct 15, 2026
Reiterated: Hold
Price Target: $750
Current: $951.19
Upside: -21.15%
Aug 12, 2026
Rated: Buy
Price Target: $10
Current: $2.77
Upside: +261.01%
Feb 11, 2026
Reiterated: Hold
Price Target: $30 → $35
Current: $69.84
Upside: -49.89%
Dec 16, 2025
Reiterated: Buy
Price Target: $51 → $81
Current: $47.77
Upside: +69.56%
Dec 16, 2025
Reiterated: Sell
Price Target: $56
Current: $61.40
Upside: -8.79%
Oct 17, 2025
Reiterated: Buy
Price Target: $31
Current: $58.12
Upside: n/a
Oct 17, 2025
Reiterated: Buy
Price Target: $73
Current: $63.36
Upside: n/a
Oct 17, 2025
Reiterated: Buy
Price Target: $101
Current: $21.04
Upside: n/a
Aug 12, 2025
Reiterated: Hold
Price Target: $40 → $30
Current: $9.59
Upside: n/a
Aug 8, 2025
Reiterated: Hold
Price Target: $3 → $2
Current: $1.33
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $14
Current: $26.47
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: $6 → $5
Current: $1.68
Upside: n/a
Dec 6, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $63.74
Upside: n/a
Dec 6, 2021
Initiated Coverage: Sell
Price Target: $11.29
Current: $0.82
Upside: n/a
Jun 13, 2021
Rated: Buy
Price Target: $12
Current: $1.32
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $27
Current: $0.3259
Upside: n/a
May 13, 2021
Reiterated: Hold
Price Target: $3
Current: $6.36
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $30
Current: $26.39
Upside: n/a
May 9, 2021
Reiterated: Hold
Price Target: $96 → $97
Current: $33.93
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: $126 → $130
Current: $425.21
Upside: n/a
May 3, 2021
Reiterated: Hold
Price Target: $7 → $6
Current: $11.43
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $6
Current: $11.67
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $13
Current: $27.58
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: €16.12 → €17.01
Current: €3.59
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $18 → $19
Current: $3.88
Upside: n/a
Feb 19, 2021
Reiterated: Hold
Price Target: €94.62 → €96.00
Current: €31.04
Upside: n/a
Sep 30, 2020
Reiterated: Buy
Price Target: €11.00
Current: €10.84
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $36.46
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $3.95
Upside: n/a
Apr 2, 2018
Reiterated: Buy
Price Target: $13
Current: $11.16
Upside: n/a
Mar 22, 2018
Reiterated: Buy
Price Target: n/a
Current: $0.0004
Upside: n/a
Mar 5, 2018
Reiterated: Buy
Price Target: $98
Current: $16.18
Upside: n/a
Nov 9, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.383
Upside: n/a
Oct 3, 2017
Reiterated: Hold
Price Target: n/a
Current: $20.67
Upside: n/a